Questcor Pharmaceuticals Inc (QCOR) Financial Statements (2024 and earlier)

Company Profile

Business Address 1300 NORTH KELLOGG DRIVE
ANAHEIM, CA 92807
State of Incorp. CA
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2014
MRQ
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 245,006155,313
Cash and cash equivalents 175,84080,608
Short-term investments 69,16674,705
Restricted cash and investments 25,000 
Receivables 87,06961,417
Inventory, net of allowances, customer advances and progress billings16,3689,909
Inventory 16,3689,909
Prepaid expense and other current assets4,900
Other undisclosed current assets 23,3335,737
Total current assets: 396,776237,276
Noncurrent Assets
Property, plant and equipment 31,7332,073
Intangible assets, net (including goodwill)50,5951,493
Goodwill 20,464 
Intangible assets, net (excluding goodwill) 30,1311,493
Deposits noncurrent assets 38970
Restricted cash and investments 50,000 
Other undisclosed noncurrent assets 206,86111,519
Total noncurrent assets: 339,57815,155
TOTAL ASSETS: 736,354252,431
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 34,48441,729
Taxes payable 3,6937,360
Employee-related liabilities 16,48921,300
Accounts payable 14,30213,069
Debt 1,665 
Other undisclosed current liabilities 125,02348,670
Total current liabilities: 161,17290,399
Noncurrent Liabilities
Long-term debt and lease obligation 13,998 
Long-term debt, excluding current maturities 13,998 
Liabilities, other than long-term debt 2,961203
Other liabilities 2,961203
Other undisclosed noncurrent liabilities 158,859 
Total noncurrent liabilities: 175,818203
Total liabilities: 336,99090,602
Equity
Equity, attributable to parent 399,364161,829
Common stock 30,38615,938
Accumulated other comprehensive income (loss) (3,253)40
Retained earnings 372,231145,851
Total equity: 399,364161,829
TOTAL LIABILITIES AND EQUITY: 736,354252,431

Income Statement (P&L) ($ in thousands)

6/30/2014
TTM
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
 798,929509,292
Cost of revenue
(Cost of Goods and Services Sold)
 (74,365)(28,555)
Gross profit: 724,564480,737
Operating expenses (284,726)(184,210)
Operating income: 439,838296,527
Nonoperating income (expense)
(loss, Foreign Currency Transaction, before Tax)
 (548) 
Other undisclosed income from continuing operations before equity method investments, income taxes 250703
Income from continuing operations before income taxes: 439,540297,230
Income tax expense (146,931)(99,555)
Income from continuing operations: 292,609197,675
Income before gain (loss) on sale of properties: 292,609197,675
Net income available to common stockholders, diluted: 292,609197,675

Comprehensive Income ($ in thousands)

6/30/2014
TTM
12/31/2013
12/31/2012
Net income: 292,609197,675
Comprehensive income: 292,609197,675
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (3,293)76
Comprehensive income, net of tax, attributable to parent: 289,316197,751

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: